Medline Inc. (MDLN)

Medline Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 28, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	1,074	1,157	1,200	234	-25
Depreciation & Amortization	1,018	1,011	977	951	933
Stock-Based Compensation	80	76	61	78	64
Other Adjustments	288	283	206	223	134
Change in Receivables	-403	-355	-256	-153	-376
Changes in Inventories	-377	-264	-545	444	-195
Changes in Accounts Payable	44	73	106	136	-103
Changes in Accrued Expenses	-54	-92	62	-112	-144
Changes in Other Operating Activities	-159	-145	-42	-116	-101
Operating Cash Flow	1,474	1,744	1,769	1,685	187
Operating Cash Flow Growth	-22.05%	-1.41%	4.98%	801.07%	-
Capital Expenditures	-445	-447	-354	-275	-254
Proceeds from Sale of Investments	-	-	-	-	7
Payments for Business Acquisitions	-16.5	-27	-1,136	-26	-17
Other Investing Activities	-	-	-3	-11	-
Investing Cash Flow	-478	-474	-1,493	-312	-264
Short-Term Debt Issued	-	179	166	-	80
Short-Term Debt Repaid	-	-179	-166	-	-80
Long-Term Debt Issued	7,569	7,569	15,932	-	-
Long-Term Debt Repaid	-11,652	-11,661	-15,995	-77	-61
Net Long-Term Debt Issued (Repaid)	-4,083	-4,092	-63	-77	-61
Issuance of Common Stock	-	7,048	-	-	-
Repurchase of Common Stock	-24	-2,003	-20	-	-
Net Common Stock Issued (Repurchased)	-24	5,045	-20	-	-
Common Dividends Paid	-366.5	-518	-1,518	-114	-23
Other Financing Activities	-13	-36	-12	-	-
Financing Cash Flow	395	399	-1,613	-191	-84
Effect of Exchange Rate Changes on Cash and Cash Equivalents	7	23	2	4	-30
Net Cash Flow	1,398	1,692	-1,335	1,186	-191
Free Cash Flow	1,029	1,297	1,415	1,410	-67
Free Cash Flow Growth	-20.66%	-8.34%	0.36%	-	-
FCF Margin	3.53%	4.56%	5.55%	6.07%	-0.31%
Free Cash Flow Per Share	1.22	1.60	-	-	-
Levered Free Cash Flow	-3,092	-2,797	1,341	1,185	50
Unlevered Free Cash Flow	1,872	2,187	2,271	2,136	-2,017

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q